The estimated Net Worth of Simon D Campion is at least $59.7 Milion dollars as of 20 November 2023. Mr Campion owns over 10,000 units of Becton Dickinson & Co stock worth over $57,003,768 and over the last 6 years he sold BDX stock worth over $1,375,674. In addition, he makes $1,305,326 as Exec. VP & Pres of Interventional Segment at Becton Dickinson & Co.
Mr has made over 4 trades of the Becton Dickinson & Co stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 10,000 units of BDX stock worth $297,000 on 20 November 2023.
The largest trade he's ever made was exercising 13,612 units of Becton Dickinson & Co stock on 4 February 2020 worth over $1,574,636. On average, Mr trades about 626 units every 35 days since 2018. As of 20 November 2023 he still owns at least 243,929 units of Becton Dickinson & Co stock.
You can see the complete history of Mr Campion stock trades at the bottom of the page.
Simon D. Campion is the Exec. VP & Pres of Interventional Segment at Becton Dickinson & Co.
As the Exec. VP & Pres of Interventional Segment of Becton Dickinson & Co, the total compensation of Mr Campion at Becton Dickinson & Co is $1,305,326. There are 13 executives at Becton Dickinson & Co getting paid more, with Vincent Forlenza having the highest compensation of $16,014,600.
Mr Campion is 50, he's been the Exec. VP & Pres of Interventional Segment of Becton Dickinson & Co since . There are 25 older and 8 younger executives at Becton Dickinson & Co. The oldest executive at Becton Dickinson & Co. is Marshall Larsen, 71, who is the Lead Independent Director.
Simon's mailing address filed with the SEC is C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC, 28277.
Over the last 22 years, insiders at Becton Dickinson & Co have traded over $106,782,599 worth of Becton Dickinson & Co stock and bought 23,860 units worth $1,771,828 . The most active insiders traders include Edward J Ludwig, William M Brown a Vincent A Forlenza. On average, Becton Dickinson & Co executives and independent directors trade stock every 20 days with the average trade being worth of $4,349,205. The most recent stock trade was executed by Roland Goette on 14 August 2024, trading 5,295 units of BDX stock currently worth $701,799.
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.
Becton Dickinson & Co executives and other stock owners filed with the SEC include: